New Capabilities Extend CyberKnife Treatment Options to Include Robotic IMRT
A research team at Vanderbilt University has developed an innovative optical system to simultaneously image electrical activity and metabolic properties in the same region of a heart, to study the complex mechanisms that lead to sudden cardiac arrest. Tested in animal models, the system could dramatically advance scientists' understanding of the relationship between metabolic disorders and heart rhythm disturbances in humans that can lead to cardiac arrest and death, and provide a platform for testing new treatments to prevent or stop potentially fatal irregular heartbeats, known as arrhythmias.
Physicians at St. David's South Austin Hospital are leading the Central Texas region in laser-assisted lead-extractions. Lead-extraction is a complicated procedure to remove leads, or transvenous pacemaker electrodes frequently used in patients with pacemakers or other implanted Cardiac Rhythm Management (CRM) devices. Recent studies have shown that using a laser can be a safe and effective way to remove cardiac leads when performed by a skilled physician. Previously, lead removal often required "open-heart" surgery.
Lutronic, Inc., a leading developer of highest quality, affordable medical and aesthetic laser systems is expanding its body contouring arsenal with the introduction of AccuSculpt(TM), making the company first-to-market with a pulsed laser to feature the revolutionary 1444 nm wavelength for a new level of safety, speed and efficiency in fat deposit emulsification and body contouring. Lutronic is the first company to research and develop the optimized 1400 wavelength for Laser Assisted Lipolysis (LAL), which also consists of the new AccuLift(TM) facial contouring procedure. The AccuSculpt system was cleared by the Food and Drug Administration (FDA) in 2008, and thousands of safe and successful face and body contouring procedures have been performed since the clearance.
The Institute for Defense and Government Advancement (IDGA), in conjunction with Adams Industries, Inc and Threat4 Xacore has announced new products that will be released during the Soldier Equipment & Technology Expo in Fayetteville, North Carolina this November 17-18.
PAIR Technologies, a start-up company established by University of Delaware researchers and a former DuPont scientist, is preparing to commercialize a high-precision detector
Look3D, a leading 3D vision company, and RealD, the world's leading 3D cinema technology company, announced today that they have reached a licensing agreement for Look3D to design, manufacture and distribute RealD 3D certified premium eyewear. Look3D eyewear will offer the same crisp, clear RealD 3D experience as eyewear currently distributed at RealD equipped theatres and will be compatible with all RealD theatres worldwide.
Luxottica Group S.p.A. (NYSE: LUX; MTA: LUX), a global leader in the design, manufacturing and distribution of fashion, luxury and sports eyewear, today announced a further expansion in the Asia-Pacific region of Sunglass Hut, the leading sunglass specialty retailer in the world.
GlassesShop.com ("GS"), the online glasses retailer, announced today that a new color tint technology for sunglasses has been successfully developed. The "CR-39 resin lens" means a milestone not only for GS, but also for the whole industry. It sets an extraordinary new benchmark.
Renaissance Laser and Vein Institute offers the latest Laser Vein Treatments to eliminate varicose and spider veins. Leg veins fall in one of three categories that define their size and severity: varicose veins, reticular veins or spider veins, all of which can receive medical vein treatment. Unfortunately, all three types of veins can become increasingly prominent and unsightly as people age, resulting in dark blue and red lines that are visible through the skin. Though covering up the veins might work in the beginning, varicose veins and spider veins tend to get worse over time and require true medical vein treatment to eliminate the problem.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.